Outlook Therapeutics, Inc. 8-K

What Happened

• Outlook Therapeutics, Inc. (OTLK) filed an 8‑K on March 10, 2026 reporting results of its Annual Meeting held that day. Of 73,509,455 shares outstanding as of the record date, 37,271,431 shares (about 50.70%) were present or represented by proxy.
• Stockholders elected three Class I directors—Yezan Haddadin, Faisal G. Sukhtian and Kurt J. Hilzinger—to serve until the 2029 Annual Meeting. The company also announced the ratification of KPMG LLP as its independent registered public accounting firm for fiscal year ending September 30, 2026, and a non‑binding advisory approval of executive compensation.

Key Details

• Director election vote totals (shares voted, excluding 21,512,399 broker non‑votes):
  • Yezan Haddadin: 14,266,442 for; 1,349,917 against; 142,673 withheld (≈90.6% support of shares voted).
  • Faisal G. Sukhtian: 14,192,499 for; 1,161,669 against; 404,864 withheld (≈90.1% support).
  • Kurt J. Hilzinger: 14,556,823 for; 972,667 against; 229,542 withheld (≈92.4% support).
• Auditor ratification (Proposal 2): KPMG LLP ratified with 35,628,284 for, 751,849 against and 891,298 abstentions (≈95.6% of shares voting in favor).
• Say‑on‑pay (Proposal 3): Non‑binding advisory approval received 13,873,653 for, 1,501,567 against and 383,812 abstentions (≈88.0% support of shares voted). There were 21,512,399 broker non‑votes on the director elections and the advisory vote.

Why It Matters

• The re‑election of the three Class I directors determines board composition and governance through the 2029 Annual Meeting, which can affect strategic oversight and shareholder engagement.
• Ratification of KPMG as auditor confirms the firm that will audit Outlook’s fiscal 2026 financial statements, an important part of financial reporting and investor confidence.
• The strong advisory support for executive compensation (non‑binding) signals shareholder acceptance of the company’s pay practices among the shares that voted, though a large number of broker non‑votes indicates many shares did not cast a vote on contested governance matters.